Benitec Biopharma Inc. (BNTC) Financials

BNTC Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 21.4 million 5.9 million
2023-09-30 27.1 million 4.7 million
2023-06-30 4.5 million 4.3 million
2023-03-31 8.2 million 3.5 million

BNTC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -5.4 million 93000
2023-09-30 -4.6 million 91000
2023-06-30 -4.1 million 127000
2023-03-31 -4.0 million 71000

BNTC Net Income

No data available :(

BNTC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 20.4 million - 423000
2023-09-30 25.9 million - 491000
2023-06-30 2.5 million - 559000
2023-03-31 6.6 million - 623000

BNTC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 2.6 million
2023-09-30 2.2 million
2023-06-30 1.6 million
2023-03-31 1.6 million

BNTC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 5.1 million 1.8 million -
2023-09-30 - 4.4 million 1.6 million -
2023-06-30 1000 3.2 million 1.4 million -
2023-03-31 1000 3.2 million 1.2 million -

BNTC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 1000
2023-09-30 - -106000
2023-06-30 7000 84000
2023-03-31 54000 32000

BNTC

Price: $8.64

52 week price:
1.86
9.01

Earnings Per Share: -236.13 USD

P/E Ratio: -0.01

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 208500

Ebitda: -11.8 million

Market Capitalization: 14.4 million

Links: